{
    "broad_study_type": "other",
    "narrow_study_type": "mechanistic_study",
    "trial_phase": "N/A",
    "observational_timeframe": "N/A",
    "justification": "research program submitted here for funding proposes to extend our recent findings in order to examine the fine structure of this gene, its expression level and function in the brain",
    "data_type": "unclear",
    "ipd_used": "individual",
    "novelty_statement": "found a novel and very specific genetic variation in the same HMG CoA reductase gene that confers natural protection against common Alzheimer's disease in humans",
    "replication_study": "N/A",
    "target_population_size": "N/A",
    "age_range": "adults",
    "gender_focus": "mixed",
    "vulnerable_populations": "yes",
    "rare_disease": "no",
    "population_description": "Alzheimer's disease subjects",
    "intervention_category": "N/A",
    "intervention_name": "N/A",
    "control_type": "N/A",
    "dose_response": "N/A",
    "combination_therapy": "N/A",
    "personalized_medicine": "yes",
    "primary_outcome": "mechanisms by which genetic anomalies in HMG-CoA reductase gene play a role in triggering/protecting against Alzheimer's disease",
    "primary_outcome_type": "surrogate",
    "safety_focus": "no",
    "quality_of_life": "no",
    "biomarker_endpoints": "yes",
    "time_to_event": "yes",
    "composite_endpoint": "no",
    "ai_machine_learning": "no",
    "digital_health": "no",
    "telemedicine": "no",
    "wearable_technology": "no",
    "big_data_analytics": "no",
    "blockchain": "no",
    "cost_effectiveness": "no",
    "budget_impact": "no",
    "health_technology_assessment": "no",
    "resource_utilization": "no",
    "productivity_outcomes": "no",
    "implementation_science": "no",
    "policy_evaluation": "no",
    "health_system_integration": "no",
    "scalability_assessment": "no",
    "barrier_identification": "no",
    "adaptive_design": "no",
    "bayesian_methods": "no",
    "machine_learning_analysis": "no",
    "novel_biostatistics": "no",
    "patient_reported_outcomes": "no",
    "real_world_evidence": "no",
    "industry_partnership": "no",
    "patient_engagement": "no",
    "community_based": "no",
    "indigenous_collaboration": "no",
    "international_collaboration": "no",
    "international_network": "no",
    "regulatory_pathway": "no",
    "ethics_focus": "no",
    "consent_innovation": "no",
    "data_sharing": "no",
    "therapeutic_area": "neurology",
    "disease_stage": "early",
    "comorbidity_focus": "no",
    "pandemic_related": "no",
    "environmental_health": "no",
    "social_determinants": "no",
    "health_equity": "no",
    "climate_health": "no",
    "urban_rural": "unclear",
    "biobank_use": "no",
    "registry_linkage": "no",
    "cohort_establishment": "no",
    "platform_trial": "no",
    "study_duration": "long_term",
    "multicenter": "no",
    "healthcare_setting": "hospital",
    "disease_area": "Alzheimer's disease",
    "methodology_innovation": "N/A",
    "knowledge_translation_focus": "yes",
    "equity_considerations": "no"
} 